Case Study

Modeling Polymer Interactions To Improve Amorphous Solid Dispersion Stability

GettyImages-2179726147 polymer

Poor solubility remains one of the most persistent obstacles in small-molecule drug development, and amorphous solid dispersions (ASDs) are a well-established strategy for addressing it. The harder problem is figuring out which polymer combinations will actually hold up, and historically that's meant running extensive experimental screens that eat time and material. There's a more targeted way to approach this.

Using molecular dynamics simulations within the OSD Predict™ framework, formulation scientists characterized intermolecular interactions between polyvinylpyrrolidone (PVP) and Eudragit polymers at the atomic level. The key finding: hydrogen bonding between Eudragit hydroxyl groups and PVP carbonyl groups is what drives stable inter-polymer complex formation in spray-dried ASDs. That's not just a structural observation, it's a selection criterion you can act on before committing to lab work.

Simulation outputs were validated against SEM, FTIR, and NMR spectroscopy data, giving the computational findings real experimental grounding. The result was a mechanistic basis for polymer selection that let the development team concentrate resources on the most viable candidates rather than screening broadly.

If your ASD programs are still running on trial-and-error polymer screening, this approach offers a more defensible, efficient alternative. Access the full case study at patheon.com/OSD to see how the modeling framework was applied.

access the Case Study!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Outsourced Pharma